Article

Overcoming Impurity Analysis And Regulatory Compliance Through Smart Supply Chain Management

Research scientist receiving drug approval virtual

Accurate analysis ensures the quality, safety, and efficacy of drug products that reach the marketplace. However, method development and validation regulations are extensive and stringent, and they are continually evolving as new therapies and analytical technology advancements are introduced. CDMOs can help their customers reach the market sooner if they anticipate evolving compliance requirements, and then implement corresponding method development and validation strategies. Those strategies should include a robust plan for supply chain security.

Evolving Regulatory Requirements

Current Good Manufacturing Practice (cGMP) shows us that the pharmaceutical industry, while highly conservative, is far from static. In their efforts to ensure continued safety and efficacy of APIs entering the consumer market, regulatory agencies are raising the standards for analytical testing. To meet these standards, - CDMOs are generating more high-value information through advances in the accuracy and precision of existing instruments, as well as the portability and high-throughput capabilities of many analytical techniques.

VIEW THE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Pharmaceutical Online? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to:

Grace Fine Chemical Manufacturing Services